Walter P Maksymowych Selected Research

Axial Spondyloarthritis

11/2022	Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.
1/2022	Improving the design of RCTs in non-radiographic axial spondyloarthritis.
1/2022	Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years.
1/2022	What Constitutes a Positive MRI for Clinical Trial Recruitment of Psoriatic Arthritis Patients With Axial Involvement?
1/2021	Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis.
1/2021	Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort.
1/2021	JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
1/2021	Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
12/2020	Update of imaging in the diagnosis and management of axial spondyloarthritis.
1/2020	Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter P Maksymowych Research Topics

Disease

61	Ankylosing Spondylitis 01/2022 - 03/2002
41	Inflammation (Inflammations) 11/2022 - 11/2002
31	Axial Spondyloarthritis 11/2022 - 02/2011
29	Rheumatoid Arthritis 12/2020 - 03/2002
18	Arthritis (Polyarthritis) 01/2020 - 08/2002
14	Non-Radiographic Axial Spondyloarthritis 09/2022 - 06/2013
11	Necrosis 01/2022 - 09/2002
10	Psoriatic Arthritis 01/2022 - 07/2002
8	Sacroiliitis 09/2022 - 06/2003
8	Back Pain (Backache) 03/2014 - 02/2004
5	Ankylosis 01/2022 - 09/2002
5	Osteoarthritis 12/2020 - 09/2010
5	Infections 01/2020 - 05/2002
4	Pain (Aches) 01/2018 - 10/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2016 - 12/2007
4	Joint Diseases (Joint Disease) 09/2015 - 05/2002
4	Osteoporosis 08/2013 - 10/2007
3	Crohn Disease (Crohn's Disease) 12/2018 - 03/2002
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2009 - 03/2006
2	Metaplasia 01/2022 - 04/2014
2	Nasopharyngitis 01/2020 - 12/2018
2	Hip Osteoarthritis (Coxarthrosis) 01/2018 - 07/2007
2	Spondylarthropathies 11/2017 - 10/2002
2	Arthralgia (Joint Pain) 04/2016 - 03/2002
2	Iritis 02/2016 - 02/2016
2	Rheumatic Diseases (Rheumatism) 04/2013 - 04/2011
2	Synovitis 09/2011 - 09/2002
2	Edema (Dropsy) 09/2011 - 10/2010
2	Disease Susceptibility (Diathesis) 02/2010 - 11/2002
2	Disease Progression 02/2010 - 11/2002
2	Palindromic rheumatism 07/2006 - 11/2002
1	Rupture 12/2020
1	Injection Site Reaction 01/2020

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2005
14	Adalimumab (Humira)FDA Link 11/2022 - 12/2007
14	C-Reactive ProteinIBA 11/2022 - 10/2005
13	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 03/2002
12	Biological ProductsIBA 11/2022 - 02/2006
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 05/2002
10	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 04/2014
10	Etanercept (Enbrel)FDA Link 01/2021 - 06/2003
10	Infliximab (Remicade)FDA Link 08/2010 - 05/2002
9	Pharmaceutical PreparationsIBA 01/2022 - 03/2002
9	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2006
8	Antirheumatic Agents (DMARD)IBA 01/2021 - 09/2015
7	Certolizumab Pegol FDA Link 09/2022 - 01/2017
7	CytokinesIBA 01/2022 - 10/2002
6	Monoclonal AntibodiesIBA 01/2021 - 12/2007
5	ixekizumabIBA 11/2022 - 12/2018
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 12/2018
5	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2019 - 09/2002
4	GLPG0634IBA 01/2022 - 12/2018
4	Interleukin-23 (Interleukin 23)IBA 01/2022 - 04/2008
4	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2021 - 06/2003
4	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 04/2012 - 07/2009
3	Janus KinasesIBA 01/2022 - 09/2018
3	upadacitinibIBA 01/2022 - 12/2019
3	HLA-B Antigens (HLA-B)IBA 11/2019 - 07/2013
3	AutoantibodiesIBA 01/2019 - 09/2015
3	Metalloproteases (Metalloproteinases)IBA 01/2019 - 12/2007
3	VimentinIBA 01/2019 - 04/2013
3	AntibodiesIBA 02/2016 - 07/2006
3	Fenofibrate (CiL)FDA LinkGeneric 01/2013 - 01/2009
2	tofacitinibIBA 01/2021 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 12/2020
2	InterleukinsIBA 12/2020 - 02/2010
2	Endothelial Growth FactorsIBA 01/2019 - 07/2015
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2019 - 07/2015
2	AminopeptidasesIBA 09/2018 - 07/2013
2	Leflunomide (Arava)FDA LinkGeneric 07/2017 - 06/2005
2	Rheumatoid FactorIBA 04/2016 - 11/2002
2	Anti-Citrullinated Protein AntibodiesIBA 04/2016 - 07/2006
2	EnzymesIBA 02/2016 - 08/2013
2	GlucocorticoidsIBA 02/2016 - 02/2016
2	Protein Isoforms (Isoforms)IBA 04/2014 - 08/2007
2	Collagen Type II (Type II Collagen)IBA 01/2013 - 08/2002
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2010 - 01/2009
2	Diphosphonates (Bisphosphonates)IBA 02/2008 - 03/2003
2	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 06/2007 - 10/2004
2	Calcineurin InhibitorsIBA 03/2006 - 08/2002
2	Methotrexate (Mexate)FDA LinkGeneric 06/2005 - 06/2003
2	Pamidronate (Aredia)FDA LinkGeneric 12/2004 - 03/2002
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	InterferonsIBA 01/2022
1	golimumab FDA Link 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2021
1	baricitinibIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020
1	DiamideIBA 12/2020
1	PhalloidineIBA 12/2020
1	Protein-Arginine DeiminasesIBA 12/2020
1	progelatinaseIBA 01/2019

Therapy/Procedure

39	Therapeutics 01/2022 - 05/2002
3	Biological Therapy 01/2018 - 10/2013
2	Contraindications 12/2019 - 06/2013
2	Physical Therapy Modalities (Physical Therapy Technique) 02/2016 - 02/2016
2	Arthroplasty 02/2016 - 02/2016
1	Drug Therapy (Chemotherapy) 01/2022